Related Experiment Video
Updated: Oct 17, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Has the Early Majority Been Reached? Specialised Inpatient Palliative Care Utilisation in Common Solid Tumours in
Marcel A Kamp1,2, Martina Kern3, Nazife Dinc4
1Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, 15562 Rüdersdorf bei Berlin, Germany.
Abstract:
Background: Randomised trials indicate that early integration of specialised palliative care improves quality of life and, in some studies, survival in advanced cancer, yet its implementation in inpatient oncology remains inconsistent. This study quantifies the coded utilisation of specialised inpatient palliative care in German hospitals and interprets adoption patterns using the diffusion of innovations theory. Methods: We conducted a cross-sectional analysis of nationwide hospital cases reimbursed under the German diagnosis-related groups (DRG) system in 2023. The analysis included the most common solid malignancies and assessed the utilisation of specialised inpatient palliative care overall and stratified by metastatic status, tumour entity, comorbidities, and treating medical specialties. Results: Specialised inpatient palliative care was provided in 5.4% of hospital cases involving the most common malignant tumours. Among patients with organ metastases, utilisation increased to a median rate of 15.0% of hospital cases, with the highest rates observed in cases with brain (17.8%), bone (17.0%), and pleural metastases (16.1%). Palliative care involvement correlated positively with in-hospital mortality. Interpreted cautiously through the diffusion of innovations theory, which frames the 15 to 20% band as a heuristic landmark rather than a validated threshold, utilisation even in the metastatic subgroup reaches only the lower edge of this band, indicating that uptake remains confined to innovators and early adopters and has not extended to the early majority. Conclusions: Specialised inpatient palliative care remains underutilised in German oncology, reaching 5.4% of all cases and a median of 15.0% even in metastatic disease. Interpreted cautiously through the diffusion of innovations theory, which frames the 15 to 20% band as a heuristic landmark, uptake appears confined to early adopters and has not yet reached the early majority.
Related Concept Videos
Treatment Resistant Cancers
Continuing Care
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...